Shuai Bo, Shen Lin, Yang Yan-ping, Xie Jing, Zhou Pi-qi, Li Heng, Guo Xiang-fei, Zhao Jia, Wu Jia-lin
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Zhongguo Gu Shang. 2008 Nov;21(11):850-3.
To investigate the effects of Chinese kidney-tonifying drugs on bone mineral density, biomechanics, 25-hydroxy Vitamin D3 and 1,25-dihydroxy Vitamin D3 of ovariectomized osteoporosis rats, and explore the mechanism of treating osteoporosis with the drugs.
Thirty-six female SD rats (four months) were randomly divided into model group, sham group and treatment group. All the rats had been ovariectomied except those in sham group. Selecting 4, 8, 12 weeks in the experiment, the value of bone mineral density (BMD) was measure by dual energy X-ray absorptiometry (DEXA) of femoral head, while the biomechanics machine was applied to analysis femoral head biomechanics index and ELISA method was used to detect the content of 25-hydroxy Vitamin D3 and 1,25-dihydroxy Vitamin D3 discern in blood-serum, liver and kidney.
Treatment group rats' BMD of femoral head was enhance compared with model group, significant differences were absent (P<0.05), and the maximal load and maximal stress measurement were improved, significant differences were absent (P<0.05). As the content of 25-hydroxy Vitamin D3 and 1,25-dihydroxy Vitamin D3 discern in blood-serum, liver and kidney were elevate, furthmore there were significant differences in group comparison, all significant differences were absent (P<0.05). But those compared with sham group, there was no significant difference (P>0.05).
In the early period in absence of estrogenic hormone, the Chinese kidney-tonifying drugs could activate bone metabolism to raise BMD and reinforce quality of bone through up-regulating expression of 25-hydroxy Vitamin D3 and 1,25-dihydroxy Vitamin D3 at protein level.
探讨补肾中药对去卵巢骨质疏松大鼠骨密度、生物力学、25-羟基维生素D3及1,25-二羟基维生素D3的影响,探讨其治疗骨质疏松的作用机制。
将36只4月龄雌性SD大鼠随机分为模型组、假手术组和治疗组。除假手术组外,其余大鼠均行卵巢切除术。分别于实验第4、8、12周,采用双能X线吸收法(DEXA)测量股骨头骨密度,应用生物力学试验机分析股骨头生物力学指标,采用酶联免疫吸附测定法(ELISA)检测血清、肝脏和肾脏中25-羟基维生素D3及1,25-二羟基维生素D3的含量。
治疗组大鼠股骨头骨密度较模型组有所提高,但差异无统计学意义(P<0.05),最大载荷和最大应力测量值有所改善,但差异无统计学意义(P<0.05)。血清、肝脏和肾脏中25-羟基维生素D3及1,25-二羟基维生素D3的含量升高,组间比较差异有统计学意义,但差异均无统计学意义(P<0.05)。与假手术组比较,差异无统计学意义(P>0.05)。
在雌激素缺乏的早期,补肾中药可通过上调蛋白质水平的25-羟基维生素D3及1,25-二羟基维生素D3表达,激活骨代谢,提高骨密度,增强骨质量。